TRG Diagnostic Imaging, Bayer Schering Pharma AG, Berlin, Germany.
Invest Radiol. 2010 May;45(5):255-61. doi: 10.1097/RLI.0b013e3181d4a036.
The iodinated contrast agents (CAs) that are currently used in radiographic procedures possess special physicochemical properties and a high safety profile; however, according to a large retrospective study (Swedish registry), the viscosity of CAs may have an underestimated impact on renal failure. The aim of our study was to investigate the possible consequences of CA viscosity differences, such as CA retention in the kidney.
Five Göttingen minipigs were each intravenously injected in a crossover setting at intervals of at least 7 days with monomeric (Iopromide) and dimeric (Iodixanol) CAs at 2 doses (1 and 2 g iodine/kg bodyweight), and the retention of the CA in the kidneys was determined during the first 6 hours postinjection using a 64-slice computed tomography scanner. Additionally we performed in vitro dialysis of the monomeric and dimeric CAs across the various physiological osmolalities of the renal tubulus (300, 600, 800, and 1200 mOsm/kg H(2)O) to estimate CA viscosity in vivo. Following the dialyzes, iodine concentrations and CA viscosities were determined.
A different exposure of the kidneys to iodine and a different elimination kinetics from the kidneys was observed after the administration of monomeric and dimeric CAs. The monomeric agent was observed to clear from the kidney immediately after administration. In contrast, after administration of the dimeric CA an increase in iodine concentration in the kidney was observed up to 180 minutes postinjection, before the CA was observed to begin clearing; however, no difference was observed between the plasma half-lives of the 2 investigated CAs. In vitro dialysis of the dimeric CA increased iodine concentrations and strongly increased viscosity at all of the tested osmolalities. In contrast, the monomeric agent only demonstrated increases in iodine concentration and viscosity at 800 and 1200 mOsm/kg, and these changes were smaller than those observed for the dimeric CA. In summary, dialysis strongly enhanced the viscosity differences between the 2 investigated CAs.
The viscosity differences between the investigated monomeric and dimeric CAs are strongly enhanced by concentration processes, such as the process taking place in the tubular system. These viscosity differences may be the cause of the prolonged retention and the different elimination kinetics from the kidney observed after application of the dimeric CA relative to the monomeric CA.
目前在放射学检查中使用的含碘造影剂(CA)具有特殊的理化性质和高安全性;然而,根据一项大型回顾性研究(瑞典登记处),CA 的粘度可能对肾衰竭的影响被低估了。我们的研究旨在探讨 CA 粘度差异的可能后果,例如 CA 在肾脏中的滞留。
在至少 7 天的间隔内,将 5 只哥廷根小型猪以交叉方式分别静脉内注射单体(碘普罗胺)和二聚体(碘克沙醇)CA,剂量为 2 种(1 和 2 g 碘/kg 体重),并在注射后 6 小时内使用 64 层 CT 扫描仪确定 CA 在肾脏中的保留情况。此外,我们在各种生理肾小管渗透压(300、600、800 和 1200 mOsm/kg H(2)O)下对单体和二聚体 CA 进行体外透析,以估计体内 CA 的粘度。透析后,测定碘浓度和 CA 粘度。
在给予单体和二聚体 CA 后,观察到肾脏对碘的不同暴露和从肾脏的不同消除动力学。单体 CA 在给药后立即从肾脏中清除。相比之下,在给予二聚体 CA 后,在观察到 CA 开始清除之前,在注射后 180 分钟内观察到肾脏中的碘浓度增加;然而,在研究的 2 种 CA 之间未观察到血浆半衰期的差异。二聚体 CA 的体外透析增加了所有测试渗透压下的碘浓度并强烈增加了粘度。相比之下,单体 CA 仅在 800 和 1200 mOsm/kg 时表现出碘浓度和粘度的增加,并且这些变化小于二聚体 CA 观察到的变化。总之,透析强烈增强了研究的 2 种 CA 之间的粘度差异。
单体和二聚体 CA 之间的粘度差异在浓度过程中被强烈增强,例如在管状系统中发生的过程。这些粘度差异可能是在应用二聚体 CA 相对于单体 CA 后观察到的肾脏滞留和不同消除动力学的原因。